
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


USANA Health Sciences Inc (USNA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: USNA (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -24.83% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 515.34M USD | Price to earnings Ratio 12.45 | 1Y Target Price 50.5 |
Price to earnings Ratio 12.45 | 1Y Target Price 50.5 | ||
Volume (30-day avg) 257195 | Beta 0.98 | 52 Weeks Range 26.19 - 49.78 | Updated Date 04/1/2025 |
52 Weeks Range 26.19 - 49.78 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.19 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.92% | Operating Margin (TTM) 3.84% |
Management Effectiveness
Return on Assets (TTM) 6% | Return on Equity (TTM) 7.76% |
Valuation
Trailing PE 12.45 | Forward PE 9.91 | Enterprise Value 362582378 | Price to Sales(TTM) 0.6 |
Enterprise Value 362582378 | Price to Sales(TTM) 0.6 | ||
Enterprise Value to Revenue 0.42 | Enterprise Value to EBITDA 3.67 | Shares Outstanding 18904500 | Shares Floating 9966466 |
Shares Outstanding 18904500 | Shares Floating 9966466 | ||
Percent Insiders 42.19 | Percent Institutions 58.41 |
Analyst Ratings
Rating 3 | Target Price 51.5 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
USANA Health Sciences Inc

Company Overview
History and Background
USANA Health Sciences, Inc. was founded in 1992 by Dr. Myron Wentz. Initially focused on manufacturing diagnostic kits, it transitioned to nutritional supplements and skincare. It became a publicly traded company in 1996 and has expanded globally.
Core Business Areas
- Nutritional Supplements: Offers a range of vitamins, minerals, and other nutritional supplements designed to support overall health and wellness.
- Skincare Products: Develops and markets skincare products focused on anti-aging and skin health.
- Food Products: Offers meal replacement shakes, bars, and other food products designed to support weight management and healthy eating habits.
Leadership and Structure
The CEO is Jim Brown. The organizational structure includes departments for Research and Development, Sales, Marketing, Operations, and Finance, with a direct selling distribution model through independent distributors.
Top Products and Market Share
Key Offerings
- CellSentials: Core nutritional supplement providing essential vitamins and minerals. Competitors: Centrum, One A Day. Market share data unavailable.
- USANA Proflavanol C100: Antioxidant supplement based on grape seed extract and vitamin C. Competitors: Life Extension, NOW Foods. Market share data unavailable.
- Celavive Skincare: Anti-aging skincare line. Competitors: Estee Lauder, L'Oreal. Market share data unavailable.
Market Dynamics
Industry Overview
The nutritional supplement and skincare industry is highly competitive and growing, driven by increasing health awareness and an aging population.
Positioning
USANA positions itself as a premium brand focused on science-based nutrition and skincare. Its competitive advantage lies in its direct selling model and perceived high-quality products.
Total Addressable Market (TAM)
The global nutritional supplements market is estimated to be over $200 billion. USANA captures a small, but significant part of this TAM with opportunity to grow with its network marketing approach.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Science-backed products
- Direct selling distribution network
- Global presence
- High-quality ingredients
Weaknesses
- Reliance on direct selling model
- Price point compared to competitors
- Negative perceptions associated with multi-level marketing
- Regulatory risks
Opportunities
- Expansion into new markets
- Development of new products
- Increased health awareness among consumers
- Leveraging digital marketing strategies
- Partnerships with health professionals
Threats
- Intense competition
- Changing consumer preferences
- Economic downturns
- Regulatory changes
- Product liability lawsuits
Competitors and Market Share
Key Competitors
- HLF
- NWL
- GNC
Competitive Landscape
USANA competes primarily with other nutritional supplement and skincare companies. Its advantages include its direct selling model and science-backed products. Disadvantages include higher prices and regulatory scrutiny.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: USANA has demonstrated moderate growth over the past decade, expanding its product line and entering new markets. However, growth has been volatile due to challenges in certain markets.
Future Projections: Analyst estimates vary, but project continued moderate growth driven by increasing demand for health and wellness products. These are estimates and should be used with caution.
Recent Initiatives: Recent initiatives include expanding into new international markets, launching new product lines, and focusing on digital marketing strategies.
Summary
USANA is a mid-sized player in the health and wellness industry with a strong direct selling distribution model. It benefits from a focus on science-backed products and a global presence. However, the company faces challenges related to competition, regulatory scrutiny, and negative perceptions associated with multi-level marketing, requiring constant innovation and market adaptation.
Similar Companies
- HLF
- NWL
- GNC
Sources and Disclaimers
Data Sources:
- USANA Health Sciences Inc. SEC filings (10-K, 10-Q)
- Company Website
- Financial News Sources
- Industry Reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is difficult to acquire with great accuracy for private companies and may not be completely exact. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About USANA Health Sciences Inc
Exchange NYSE | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 1996-07-25 | CEO & President Mr. Jim Brown | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 1700 | Website https://www.usana.com |
Full time employees 1700 | Website https://www.usana.com |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.